CVi delivers the power to improve patient safety, minimizing the risk of contrast-induced acute kidney injury (CI-AKI) for coronary catheterizations when compared to manual injection of contrast media.
It's the contrast injector for:
- Interventional cardiologists who want to regulate contrast injection flow and minimize risk of CI-AKI—also referred to as contrast induced nephropathy (CIN)
- Hospital administrators interested in cost containment through cath lab safety and efficiency and reducing potential patient post-procedure adverse events
No literature available.
No resources available.
No contacts available.
Please fill out the form below and we will get back to you.